Why Did the FDA Try to Discredit Ivermectin During COVID in 2021?
Just as a reminder as to what an amazing medicine ivermectin is: Ivermectin was discovered in the late 1970s through a collaborative effort between the Kitasato Institute in Japan and Merck & Co. Satoshi Ōmura, a microbiologist at Kitasato, isolated a novel Streptomyces bacterium (S. avermitilis) from a soil sample collected near a golf course in Shizuoka Prefecture, Japan, and cultured it for analysis. William Campbell, a parasitologist at Merck, then tested Ōmura's bacterial cultures and identified the potent antiparasitic activity of the fermentation products, which were named avermectins. A chemically modified derivative — 22,23-dihydroavermectin B₁, branded as ivermectin — proved to be both more potent and better tolerated. It was first approved for veterinary use in 1981 and rapidly became one of the most widely used antiparasitic agents in livestock and companion animals. Its transition to human medicine came in 1987, when Merck made the landmark decision to donate the drug indefinitely for the treatment of onchocerciasis (river blindness) in endemic regions of Africa and Latin America — one of the most celebrated acts of pharmaceutical philanthropy in history. It was subsequently approved for human use against strongyloidiasis and other helminthic infections, and its impact on global neglected tropical diseases was so profound that Ōmura and Campbell were jointly awarded the Nobel Prize in Physiology or Medicine in 2015. In subsequent decades, ivermectin attracted research interest well beyond parasitology, including studies on its antiviral properties and, more recently, its potential anticancer mechanisms — areas that remain active fields of investigation.
Ivermectin is one of the safest medicines in the world, on par with fenbendazole and other antiparasitics like albendazole that are given to billions of people every year as part of public health mass drug administration initiatives to control parasitic infections (Kory, 2021; WHO, 2023).
As discovered and detailed in the book, Cancer is a Parasite, nations around the world that use antiparasitics like fenbendazole as part of public health mass drug administration initiatives have at least one-half the cancer incidence rate of nations like the US that do not have any such programs (despite undiagnosed, asymptomatic, untreated epidemic-scale parasitic infections that are themselves chronic inflammation-based cancer risk factors in the US population according to the CDC). For example the US has a cancer incidence rate of over 300/100k while India has under a 100/100k rate. Virtually every one of the 123 nations of the world that use antiparasitics have at least half the cancer incidence rate of the 62 mostly Western, definitely wealthy, nations that don’t!
So the answer to today’s question: Why did the FDA try to discourage people from trying ivermectin as a treatment for COVID? Because antiparasitics like ivermectin and fenbendazole, with their proven anticancer actions, would have inadvertently dramatically lowered the cancer incidence rate in the US and other nations that used ivermectin as a COVID treatment and would have destroyed the lucrative cancer treatment business. That’s why. If there is a better explanation, please, let’s hear it.
“Thou shalt not bow down thyself to them, nor serve them: for I the LORD thy God am a jealous God, visiting the iniquity of the fathers upon the children unto the third and fourth generation of them that hate me; - Exodus 20:5
BOMBSHELL: Former Pussycat Dolls Member Gravely Injured by COVID Jab Says “Deadly Lot” Also Killed Her Mom
Jessica Sutta says she lost her health, her mother, and her Hollywood career after speaking out and warns that “too many people are dying” while society normalizes it.
“Thou shalt not bow down thyself to them, nor serve them: for I the LORD thy God am a jealous God, visiting the iniquity of the fathers upon the children unto the third and fourth generation of them that hate me; - Exodus 20:5